Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample

To see complete record on, please visit this link

Id: NCT05322954

Organisation Name: University of Wisconsin, Madison

Overal Status: Recruiting

Start Date: January 2023

Last Update: January 10, 2023

Lead Sponsor: University of Wisconsin, Madison

Brief Summary: The purpose of this research study is to investigate the safety and feasibility of two (2) oral doses of psilocybin when combined with behavioral support for methamphetamine use disorder (MUD). Participants have a diagnosis of methamphetamine use disorder (MUD). Participants can expect to be actively engaged in the study for up to 26 weeks.

  • Methamphetamine Use Disorder
  • Substance-Related Disorders
  • Chemically-Induced Disorders
  • Substance Use Disorders
  • Stimulant-Use Disorder

Total execution time in seconds: 0.19585394859314